Crescendo Biologics appoints new CMOCrescendo Biologics Ltd (Crescendo), today announced that Pavel Pisa, MD, PhD, has been appointed as Chief Medical Officer of the Company with immediate effect. more ➔
Changes at Arix BioscienceArix Bioscience, a healthcare and life science company, today announces planned changes to its executive team to prepare for its next phase of growth and development. Dr Joe Anderson, who has served … more ➔
New Secretary General & Directors at...EuropaBio today confirmed the appointment of Joanna Dupont-Inglis as its new Secretary General. Commenting on this promotion, EuropaBio chair, Tjerk de Ruiter, said Joanna has an excellent track record … more ➔
Changes at Roche – Diagnostics CEO t...Roche today announced that Roland Diggelmann, CEO Diagnostics Division and member of the Corporate Executive Committee, will be leaving Roche to pursue his career outside of the company effective 30 … more ➔
Congenica Appoints Wendy Britten as CFOCongenica today announced the appointment of Mrs Wendy Britten as its new Chief Financial Officer (CFO), effective 1st September, 2018. Mrs Britten will have overall control and responsibility for all … more ➔
Greg Rush joins Parexel as Executive VP &#...Parexel International Corporation today announced the appointment of Greg Rush as Executive Vice President and Chief Financial Officer. more ➔
Zelluna appoints Dr. Namir HassanZelluna Immunotherapy, a biotechnology company specializing in T-cell receptor (TCR) immunotherapies, has announced the appointment of Dr. Namir Hassan as chief scientific officer (CSO). more ➔
Novartis names Klaus Moosmayer as Chief Et...Novartis announced today the appointment of Dr Klaus Moosmayer as Chief Ethics, Risk and Compliance Officer. He will report to Vas Narasimhan, M.D., CEO of Novartis and become a member of the Executive … more ➔
Sphere Fluidics appoints Dr Tris VaughanSphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, announced today that Tris Vaughan, PhD FRSB has joined its scientific advisory board … more ➔
Cellectis Appoints Stefan SchererCellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), announced today the appointment of Dr. Stefan Scherer, … more ➔
